4.2 Project income Income source Income £ none £0 Total Project Income The project will highlight areas of unwarranted variation across the West Midlands for MS patients. It will also identify the implications of new NICE approved treatments and where issues exist in the system which restrict access. Benefits Realisation Plan Benefit How will this How will this Baseline Key date for description be realised be measured measure benefit and link to realisation which objective Understanding By an analysis Through patient Zero no November 14 by of the and measure of a commissioners professional professional West Midlands and providers map, the evaluation exists of the West outputs from Midlands the experience landscape of of care focus MS services groups and the (obj. 1, 2 and 3) validation by data Understanding By working Incorporation in No WM November14 of the impact of with clinicians to specialised pathways for New NICE and commissioning DMT are held approved pharmacists to plans by the disease determine specialist modifying what drugs are commissioners treatments in the pipeline and what the impact of their introduction
4.2 Project income Income source Income £ none £0 Total Project Income The project will highlight areas of unwarranted variation across the West Midlands for MS patients. It will also identify the implications of new NICE approved treatments and where issues exist in the system which restrict access. Benefits Realisation Plan Benefit description and link to which objective How will this be realised How will this be measured Baseline measure Key date for benefit realisation Understanding by commissioners and providers of the West Midlands landscape of MS services (obj. 1, 2 and 3) By an analysis of the professional map, the outputs from the experience of care focus groups and the validation by data Through patient and professional evaluation Zero no measure of a West Midlands exists November 14 Understanding of the impact of New NICE approved disease modifying treatments By working with clinicians and pharmacists to determine what drugs are in the pipeline and what the impact of their introduction Incorporation in to specialised commissioning plans No WM pathways for DMT are held by the specialist commissioners November14